Heilongjiang Zbd Pharmaceutical Co., Ltd. Class ASSE: 603567

Announcement on Postponement of Disclosure of 2025 Annual Report

· Issued by Heilongjiang Zbd Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Postponement of Disclosure of 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment